desacetylnantradol has been researched along with am-356 in 1 studies
Studies (desacetylnantradol) | Trials (desacetylnantradol) | Recent Studies (post-2010) (desacetylnantradol) | Studies (am-356) | Trials (am-356) | Recent Studies (post-2010) (am-356) |
---|---|---|---|---|---|
18 | 0 | 0 | 216 | 0 | 42 |
Protein | Taxonomy | desacetylnantradol (IC50) | am-356 (IC50) |
---|---|---|---|
Potassium channel subfamily K member 3 | Homo sapiens (human) | 0.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berglund, BA; Boring, DL; Howlett, AC; Lin, S; Makriyannis, A; Wilken, GH | 1 |
1 other study(ies) available for desacetylnantradol and am-356
Article | Year |
---|---|
Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamide groups.
Topics: Adenylyl Cyclases; Animals; Arachidonic Acids; Binding Sites; Brain; Cannabinoids; Cell Line; Cell Membrane; Endocannabinoids; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Palatine Tonsil; Phenanthridines; Polyunsaturated Alkamides; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction; Stereoisomerism; Thermodynamics | 1998 |